GSK ends Arzerra patent dispute with Genentech and nonprofit

03/27/2012 | Reuters

Genmab said marketing partner GlaxoSmithKline resolved a patent dispute with Roche Holding unit Genentech and California nonprofit City of Hope concerning Genmab's blood cancer drug Arzerra, or ofatumumab.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC